4556 — Kainos Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual balance sheet for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,964	2,244	2,677	3,020	3,174
Net Total Accounts Receivable
Net Total Receivables	1,201	1,206	1,333	1,411	1,566
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,806	4,058	4,690	5,219	5,694
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,539	2,532	2,535	2,547	2,506
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	6,745	6,962	7,572	8,116	8,591
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,848	1,894	1,781	1,916	1,980
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,363	2,303	2,371	2,446	2,325
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	4,381	4,660	5,200	5,670	6,266
Total Liabilities & Shareholders' Equity	6,745	6,962	7,572	8,116	8,591
Total Common Shares Outstanding